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General cognitive ability (g), which refers to what cogni-
tive abilities have in common, is an important target for
molecular genetic research because multivariate quanti-
tative genetic analyses have shown that the same set of
genes affects diverse cognitive abilities as well as learn-
ing disabilities. In this first autosomal genome-wide
association scan of g, we used a two-stage quantitative
trait locus (QTL) design with pooled DNA to screen more
than 500 000 single nucleotide polymorphisms (SNPs) on
microarrays, selecting from a sample of 7000 7-year-old
children. In stage 1, we screened for allele frequency
differences between groups pooled for low and high g.I n
stage 2, 47 SNPs nominated in stage 1 were tested by
individually genotyping an independent sample of 3195
individuals, representative of the entire distribution of g
scores in the full 7000 7-year-old children. Six SNPs
yielded significant associations across the normal distri-
bution of g, although only one SNP remained significant
after a false discovery rate of 0.05 was imposed. How-
ever, none of these SNPs accounted for more than 0.4%
of the variance of g, despite 95% power to detect
associations of that size. It is likely that QTL effect sizes,
even for highly heritable traits such as cognitive abilities
and disabilities, are much smaller than previously
assumed. Nonetheless, an aggregated ‘SNP set’ of the
six SNPs correlated 0.11 (P < 0.00000003) with g. This
shows that future SNP sets that will incorporate many
more SNPs could be useful for predicting genetic risk and
for investigating functional systems of effects from
genes to brain to behavior.
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The phenomenon of general cognitive ability was discovered
more than a century ago and was called g to distinguish it from
the many connotations of the word intelligence (Spearman
1904). The phenomenon is that individual differences in
diverse cognitive abilities such as verbal, spatial, memory
and processing speed correlate about 0.30 on average, and
a general factor (an unrotated first principal component)
accounts for about 40% of the total variance, as indicated in
a meta-analysis of more than 300 studies (Carroll 1993;
Jensen 1998). g is one of the most reliable, valid and stable
behavioral traits, and it predicts important social outcomes
such as educational and occupational levels far better than
any other trait (Deary et al. 1994; Gottfredson 1997; Neisser
et al. 1996; Schmidt & Hunter 2004).
The substantial heritability of g is documented in dozens of
family, twin and adoption studies, with estimates varying
from 40% to 80% and generally increasing with age
(Bouchard & McGue 1981; Deary et al. 2006; Plomin &
Spinath 2004). Most importantly, multivariate genetic analy-
ses have consistently shown that genetic effects on cognitive
abilities largely operate at the level of g. That is, genetic
correlations among diverse cognitive abilities consistently
exceed 0.50 and are often near 1.0 across diverse cognitive
abilities including basic information-processing measures
(Deary et al. 2006). This genetic overlap across cognitive
abilities becomes stronger across the life span (Petrill 2002).
In other words, these multivariate genetic results predict that
genes found to be associated with one cognitive ability are
likely to be associated with other cognitive abilities as well.
Conversely, attempts to find genes for specific cognitive
abilities independent of g are less likely to succeed, not
because they do not exist (the genetic correlations are less
than 1.0) but because what is in common among cognitive
abilities is largely genetic and what is independent is largely
environmental (Plomin & Spinath 2002). Recent multivariate
genetic research has suggested that the general effects of
genes on g extend beyond traditional cognitive abilities:
genetic correlations exceeding 0.50 were also found between
g and learning abilities and disabilities such as reading,
language and mathematics (Plomin & Kovas 2005).
For these reasons, as well as for the far-reaching implica-
tions of g for molecular genetics (Butcher et al. 2006) and
cognitive neuroscience (Kovas & Plomin 2006), g is an
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doi: 10.1111/j.1601-183X.2007.00368.x 435important target for attempts to identify genes responsible
for these general effects on cognitive abilities. As for most
other quantitative traits and common disorders, progress
toward identifying g genes has been slow. A review of
monogenic disorders found 282 that involve low g (Inlow &
Restifo 2004), including phenylketonuria and fragile X syn-
drome, but these are rare and, in total, account for less than
1% of low g cases and a much smaller proportion of the
normal range of variation in g. Dozens of common variants in
candidate gene studies have been reported to be associated
with g but, other than a small effect of the E4 allele of APOE
(MIM 107741) on g in older people (Small et al. 2004), no
consistent replications have emerged in studies large enough
(and therefore powerful enough) to detect the small genetic
effects likely to underpin g (Payton 2006; Plomin et al. 2006;
Posthuma & De Geus 2006; Savitz et al. 2006). This lack of
replication is typical of candidate gene research on quantita-
tive traits and common disorders (Hirschhorn et al. 2002;
Ioannidis et al. 2001), although replication is better with larger
samples (Lohmueller et al. 2003). The odds ratio for replicated
results in candidate gene studies with large samples was only
1.2 (Ioannidis et al. 2006), which has daunting implications for
sample sizes. For example, between 2000 and 9500 cases
are required to detect a disease-conferring variant with an
odds ratio of 1.4, depending on the disease allele frequency
(0.50 and 0.05, respectively). Moreover, these estimates
increase if the disease variant is rarer than the genotyped
marker (Zondervan & Cardon 2004).
Rather than focusing on a small number of candidate
genes, genome-wide linkage provides a more systematic
search. From five reports of genome-wide linkage scans of
g involving two independent samples, significant or sugges-
tive linkage was found in three reports in a region linked in
other studies to reading disability (6p25-21) (Dick et al. 2006;
Luciano et al. 2006; Posthuma et al. 2005) but not in two other
reports based on these same samples (Buyske et al. 2006;
Wainwright et al. 2006). Two dozen other possible linkage
regions were also reported, few of which overlapped across
studies (Posthuma & De Geus 2006), which is also typical of
linkage research on quantitative traits and common disorders
(Altmu ¨ller et al. 2001). Because linkage designs are powerful
for detecting genes of large effect size, one safe conclusion
from these linkage studies is that there are unlikely to be any
genes that have a large effect on g, for example accounting
for more than 10% of the variance (Sham et al. 2000).
Allelic association is more powerful than linkage for detect-
ing quantitative trait loci (QTLs) of small effect size (Risch
2000; Sham et al. 2000), but until recently, association studies
have not been systematic like linkage; that is why linkage
studies remained popular and association studies have been
limited to candidate genes. Genome-wide association scans
are now possible using single nucleotide polymorphism (SNP)
microarrays (Hirschhorn & Daly 2005), although many issues
remain to be resolved such as gene-centered vs. genome-
centered approaches, common vs. rare variants, sample size
and design (Carlson et al. 2004; Newton-Cheh & Hirschhorn
2005; Thomas et al. 2005; Wang et al. 2005). However,
despite the decreasing costs of microarrays, they remain
expensive for genotyping the very large samples needed to
detect and replicate QTLs of small effect size. One econom-
ical strategy for screening large samples is to pool DNA for
groups such as cases and controls for a disorder or low and
high groups for a quantitative trait, which averages allele
frequencies biologically for the comparison groups rather than
obtaining individual genotypes and averaging them statisti-
cally (Darvasi & Soller 1994; Knight & Sham 2006; Norton
et al. 2004; Sham et al. 2002). We have previously used
pooled DNA in attempts to move toward more systematic
association analyses of g in a study of 1842 short-sequence
repeat markers (Plomin et al. 2001) and in a study of 432
nonsynonymous SNPs in genes expressed in the brain
(Butcher et al. 2005a). However, these studies were con-
ducted before microarrays became available and did not begin
to approach genome-wide scans.
We have combined the strengths of microarrays and
pooled DNA in a method we call ‘SNP Microarrays and
Pooling (SNP-MaP)’. Pooled DNA can be genotyped reliably
on microarrays (Butcher et al. 2004; Docherty et al. 2007;
Kirov et al. 2006; Meaburn et al. 2005, 2006; Pearson et al.
2007). We used the SNP-MaP method with a microarray with
11 555 SNPs to identify four SNPs associated with g in 7-
year-olds in a multistage design that included confirmation by
individual genotyping of the SNPs (Butcher et al. 2005b).
However, the average effect size of the four SNPs was just
0.2%, and these SNPs were only detected as significant
because the sample was so large (n ¼ 6154). Nonetheless,
combining these SNPs in an aggregated g ‘SNP set’ yielded
significant associations with g as early as 2 years of age,
significant associations with reading at 7 years and several
examples of significant genotype–environment interaction
and correlation (Harlaar et al. 2005).
Because 11 555 SNPs do not represent a genome-wide
scan, the purpose of the present study was to apply the SNP-
MaP approach to a genome-wide scan for g using the
Affymetrix GeneChip
 Human Mapping 500K Array set
(Affymetrix, Santa Clara, CA, USA).
Materials and methods
Participants
The Twins Early Development Study (TEDS) is a large, longitudinal
study set up to investigate the genetic and environmental bases of
cognitive and behavioral development (Oliver & Plomin 2007; Trouton
et al. 2002). The TEDS recruited families of twins born in England and
Wales in 1994, 1995 and 1996. Nearly 16 000 families were con-
tacted, of whom over 11 000 agreed to participate. Participation
entailed completing booklets shortly after the birth of the twins,
detailing a comprehensive range of background variables, followed by
questionnaire booklets before the children’s birthdays. At 7 years,
7924 children (members of 4039 twin pairs) were assessed for
cognitive abilities and also provided DNA. The sample is representa-
tive of the UK population (ascertained by comparison with census
data from the Office of National Statistics), although fewer mothers of
twins are in full-time work outside the home. We excluded children
with severe current medical problems, children who had suffered
severe problems at birth or whose mothers had suffered severe
problems during pregnancy. Unknown or uncertain zygosity was also
grounds for exclusion as were any twins whose first language was
other than English. Finally, in order to avoid issues of population
stratification, we included only twins whose parents reported their
ethnicity as ‘white’, which is 94% of the sample. This ‘foundation
sample’, from which the children in the present study were selected,
included 7089 children.
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g was assessed using two tests of verbal cognitive abilities and two
nonverbal tests. The verbal tests consisted of the Similarities test
(e.g. ‘in what way are milk and water alike?’) and the Vocabulary test
(e.g. ‘what does ‘‘strenuous’’ mean?’), both from the Wechsler
Intelligence Scale for Children (Wechsler 1992). The nonverbal tests
were the Picture Completion test from the Wechsler Intelligence
Scales for Children–3rd Edition UK (WISC-III-UK; Wechsler 1992) and
Conceptual Grouping from the McCarthy Scales of Children’s Abilities
(McCarthy 1972). The tests were administered during a telephone
interview, a method that has shown to be highly valid compared with
in-person testing (Petrill et al. 2002). Prior to the telephone interview,
parents were sent a sealed booklet of test items along with
instructions indicating, for example, that the test booklet should not
be opened prior to the telephone interview and that the twins should
not be in the same room for the duration of the call.
A general factor was extracted from the four tests using principal
components analysis. As the factor loadings were similar for the four
tests, the g score used in the analysis was calculated as the sum of
the standardized test scores. These unit-weighted scores correlated
0.99 with factor scores derived from the first principal component.
Design and procedures
Stage 1: SNP-MaP screen of low vs. high groups
A 1 standard deviation cut-off (i.e. corresponding to the top and
bottom 16th percentiles) was used to select one member of a twin
pair from the g score distribution of foundation sample of TEDS
children, resulting in 458 low g children and 402 high g children, with
approximately equal numbers of boys and girls in each group. There
were 653 individuals (75.9%) from this stage who were present in the
pooled DNA stage of Butcher et al. (2005b). The mean standardized g
score was  1.5 for the low group and 1.6 for the high group. The low
and high groups were each divided into 10 independent DNA pools
(biological replicates) with about 40 children in each pool; each
individual was randomly assigned to one pool. The 20 DNA pools
were allelotyped on Affymetrix GeneChip Human Mapping 500K
Arrays as a screen for allele frequency differences between the low
and high g groups.
Stage 2: testing the QTL hypothesis by individually
genotyping SNPs nominated by SNP-MaP in an
unselected sample
In stage 2 of the study, the QTL hypothesis was tested by individually
genotyping the remaining foundation sample after excluding stage 1
individuals and selecting one twin per pair. This provided 3195
individuals representative of the entire distribution of gscores (z-score
range of the sample was  3.5 to 4.9). There were 2650 individuals
(82.9%) from this stage who were present in individual genotyping
stage of our 10K SNP-MaP study (Butcher et al. 2005b). The sample
provides 100%, 98% and 71% power to detect an additive single-
locus genetic effect explaining 1%, 0.5% and 0.2% of the total
variance of g scores, respectively, uncorrected for multiple testing
(P < .05, one tailed) (Purcell et al. 2003).
DNA pool construction
Genomic DNA for each individual, extracted from buccal swabs
(Freeman et al. 2003) and suspended in Tris-ethylenediaminetetra-
acetic acid [EDTA] (TE) buffer (0.01 M Tris–HCl, 0.001 M EDTA, pH
8.0), was quantified in triplicate using PicoGreen double-stranded
DNA quantification reagent (Invitrogen, Carlsbad, CA, USA). Upon
obtaining reliable triplicate readings, each individual contributed the
same amount of DNA to their respective pool. Because individual
samples differed in their concentrations, individual DNAs were
adjusted to produce equimolar DNA contributions to the pools. We
deemed 1 ml the minimum volume that could be added to a pool
without compromising pipette error. Therefore, the amount of DNA
contributed to the pools was determined by the mass of DNA
contained in 1 ml of the most concentrated individual, in this case
98.6 ng/ml. Each individual therefore contributed 98.6 ng to the DNA
pool. The range of concentrations was 14.7–17.2 ng/ml for the 10
pools from the low g group and 15.7–17.2 ng/ml for the 10 pools from
the high g group.
Single nucleotide polymorphism microarray
allelotyping of pooled DNA
Each of the 20 DNA pools was allelotyped using the Affymetrix
GeneChip Human Mapping 500K Array set in accordance with the
standard protocol for individual DNA samples (see the GeneChip
Human Mapping 500K Assay manual for full protocol). Each micro-
array was scanned using the GeneChip
 Scanner 3000 with high-
resolution scanning upgrade, which was controlled using GENECHIP

operating software (GCOS) version 1.4. Cell intensity (.cel) files were
analyzed using GTYPEv.40. For quality control checks, a reference DNA
individual provided by the manufacturer (sample number 100103) was
also assayed on a separate microarray set.
Generation of SNP-MaP allele frequency estimates
Relative allele signal scores, calculated using the 10K MPAM Map-
ping algorithm, have been shown to be reliable and valid indices of
allele frequency in pooled DNA (Brohede et al. 2006; Butcher et al.
2004; Craig et al.2005; Kirov et al. 2006; Liu et al. 2005; Meaburn et al.
2005, 2006; Simpson et al. 2005). We present details of how probe
sets on Affymetrix GeneChip Human Mapping microarrays are used
to calculate the allele frequency estimates as Supplementary Materi-
als and Methods in Appendix S1. Allele frequency estimates for the
500K microarray set were calculated manually from the raw probe
intensity data exported as a .txt file.
Selection of SNPs from stage 1
To select SNPs for individual genotyping, we derived a rank-based
composite score using five criteria from the stage 1 data set. The
derivation of this composite score is presented as Supplementary
Materials and Methods in Appendix S1. Briefly, the five criteria were
(1) greater average allele frequency difference between low and high
g groups, (2) smaller average variance of the low and high g groups
(i.e. variance across the DNA pooled allele frequency estimates for
each group), (3) smaller average variance within each microarray (i.e.
variance across the multiple probe sets that form the microarray’s
allele frequency estimate), (4) greater number of successful replicate
pools and (5) greater minor allele frequency, as indexed by the
average of the low and high g groups. Because we expect many
more putatively significant associations from stage 1 than could be
realistically individually genotyped (>5000, P < .01), we used this
composite to choose the top 47 SNPs with the highest composite
scores. The SNP screen was restricted to the autosomes because the
DNA pools included both boys and girls, which complicates analyses
of SNPs on the X chromosome.
Individual genotyping in stage 2
After excluding stage 1 individuals and selecting just one twin per
pair, the 3195 individuals described earlier were genotyped using the
Applied Biosystems’ SNPlex genotyping system and analyzed
using GENEMAPPER version 4.0 software (Applied Biosystems, Foster
City, CA, USA). SNPlex is a capillary electrophoresis-based multiplex
genotyping system capable of genotyping up to 48 SNPs per sample
per well (Tobler et al. 2005). In addition to the 3195 TEDS individuals,
88 CEPH individuals who have been genotyped as part of the
HapMap Project (The International HapMap Consortium 2003,
2005) were obtained from the Coriell Institute to assess genotyping
quality and error rate. For selected SNPs, reference genotypes of
individuals from the Centre de l’Etude du Polymorphisme Humain
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Genome-wide association study for g(CEPH) were downloaded from HapMart, the data mining tool for
downloading HapMap data (http://hapmart.hapmap.org/BioMart/
martview).
Because quantitative genetic research strongly suggests that the
majority of genetic effects are additive, we were primarily interested
in testing SNPs for their additive effect. Therefore, genotypes of SNPs
passing quality control (see below) were tested for additive genetic
effects using a Pearson correlation (r) and coding the three observed
genotypes such that 0 ¼ AA, 1 ¼ AB and 2 ¼ BB. In addition, we
followed a procedure recommended by Balding (2006) to test
whether a nonadditive model predicted significantly better than an
additive model.
Genotyping quality control
The following sequential criteria were applied: SNPs were omitted
from analysis if either poor genotype clusters prevented GENEMAPPER
software from making calls or a SNP showed more than one genotype
mismatch between CEPH genotypes deposited in HapMap and those
derived using in-house genotyping methods. Individuals were omitted
if their SNP call rate was <80%. Finally, for each SNP, individual
genotypes were omitted if their peak heights were <25% of the
average peak height for that genotypic group as measured across the
entire sample.
Results
Stage 1: SNP-MaP screen of low vs. high groups
SNP-MaP allele frequencies for the 20 DNA pools were
calculated. In order to increase the reliability of SNP-MaP
allele frequency estimates, we required allele frequency
estimates from a minimum of six (out of 10) replicates
for both high and low groups. We also excluded SNPs with
minor allele frequencies lower than 0.05 as power to detect
association in this range is greatly reduced. After these
exclusion criteria, the autosomal genome-wide screen con-
sisted of 449 127 SNPs from the 500K microarray set.
The average allele frequency for the low and high g groups
was calculated for each SNP. The correlation between the
low and high g groups was 0.993, indicating that the rank
order of allele frequencies was highly reliable overall – a test
analogous to genome control. Accordingly, between-group
differences were small: Figure 1 illustrates that 90% of the
SNPs exhibited between-group differences smaller than 0.05,
with a mean between-group absolute difference of 0.025 for
the whole data set (range: 0.00–0.27).
As explained in Materials and methods, SNPs selected for
individual genotyping were chosen on the basis of a ranked
composite score, which took into account the between-
group allele frequency difference, variance between and
within biological replicate microarrays, number of success-
fully assayed arrays and minor allele frequency. Because of
financial restrictions, we were limited to genotyping a single
probe set of 47 SNPs with the highest composite scores. The
mean absolute difference between low and high SNP-MaP
allele frequency estimates for these was 0.108 (ranging from
0.05 to 0.26). The SNP with the largest difference was not
selected as it exhibited high levels of variance and the
minimum number of replicates, which counted unfavorably
in the composite measure. Figure 2 illustrates the 47
selected SNPs in the context of the full data set by plotting
the average allele frequency of the low g group against that of
the high g group. Using conventional parametric statistical
methods (Student’s t-test) to test for allele frequency differ-
ences between the 10 pools for the low g group and the 10
pools for the high g group, all SNPs were significant at
P < 0.05 (range: 0.0000002   P   0.03). However, the
composite selection criterion goes beyond traditional P-
values to incorporate variance between and within groups,
as well as the variance of a single SNP’s measurement on
a single microarray. Details about the 47 selected and
successfully genotyped SNPs can be found in Table S1 in
Appendix S1.
Individual genotyping quality control
On a study-wide level of analysis, five out of 47 SNPs failed to
call because of poor genotype clustering and were omitted;
five SNPs were also omitted that showed unacceptably high
genotyping error rates (measured by the concordance
between our in-house-derived genotypes for 88 CEPH indi-
viduals and the genotypes of the same CEPH individuals
available from HapMap); for the 37 SNPs passing these
quality control criteria, we observed 9 mismatches out of
2981 genotypes (error rate 0.3%). Of these errors, there was
bias toward calling heterozygotes.
Figure 1: A histogram illustrating the distribution of abso-
lute allele frequency differences between low and high g
groups derived through pooled DNA on microarrays. The
y-axis indicates the number of SNPs with differences correspond-
ing to those on the x-axis. The figure shows that the vast majority
of allele frequency differences are small and that the mean allele
frequency between low and high g groups is about 0.025. The
x-axis is elongated to accommodate outliers, which are a logical
source of candidate SNPs to follow up; the extreme end of this
scale is magnified for clarity and detail (inset). The total number of
SNPs is less than the total number of autosomal SNPs because
SNPs represented by fewer than six out of 10 replicates were
removed.
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rates (<80%) were omitted; fragmented DNA is a prerequi-
site to running SNPlex, and overfragmentation is the likely
cause of these low call rates. At the SNP level of analysis,
we excluded an additional approximately 4% of SNP
genotypes whose peak height was <25% of the average
peak height for that SNP across the study. At the cost of
reduced sample size, these conservative criteria improved
observed genotypic distributions under Hardy–Weinberg
expectation, tightened genotype clusters and left the dis-
tribution of g unchanged. The effective sample size was
n ¼ 2782.
Stage 2: testing the QTL hypothesis by individually
genotyping SNPs nominated by SNP-MaP in an
unselected sample
The 37 successfully genotyped SNPs nominated by stage 1
were individually genotyped across the unselected sample of
2782 children in order to test the QTL hypothesis directly by
assessing the extent to which the SNPs are associated with g
throughout the distribution. Each individual’s genotypes for
the 37 SNPs were tested for additive genotypic effects. With
37 tests and an alpha of 0.05, two significant results would be
expected on the basis of chance alone. As shown in Table 1,
six SNPs (16%) were significantly associated with individual
differences in g throughout the distribution using a nominal
one-tailed alpha level of 0.05 (range: 0.0007   P   0.043).
We used a one-tailed test because the difference observed in
stage 2 was required to be in the same direction as that seen
in stage 1 screening. None of the six SNPs significantly
deviated from Hardy–Weinberg expectation. A summary of
stage 1 and 2 results for all 37 SNPs (including SNP locations)
is provided in Table S1. After correcting for 37 simultaneous
tests using a step-up false discovery rate (Benjamini &
Hochberg 1995) of 0.05, only the most strongly associated
SNP remained significant (corrected P < 0.03). However, the
other nominally significant SNPs were also included in our
SNP set (see below).
The significant correlations are small, with an average
correlation (r) across the six SNPs of 0.043; the largest
correlation is 0.062 (rs1378810, P ¼ 0.0007). Squaring these
correlations (r
2) to estimate effect size indicates that these
associations account from only 0.1% to 0.4% of the variance
of g scores. The average effect size is 0.2%, and the sum of
the effect sizes of the six SNPs is 1.2%. Following the
procedure suggested by Balding (2006), we compared addi-
tive and nonadditive models and found that the additive
model fits best for all six SNPs (data not shown). We also
examined the associations separately for boys and girls, but
no significant differences were found; because our screening
design included boys and girls, it would favor SNPs that show
effects in both sexes.
Figure 3 presents the results for the six significant SNPs in
terms of standardized mean quantitative trait g scores (age
and sex regressed) for the three SNP genotypes. For the first
five SNPs, the nonoverlapping standard error bars indicate
that the homozygote genotypes differ significantly on g. For
the sixth SNP (Fig. 3f), the significant difference is between
the heterozygote (CG) and one homozygote (GG), the geno-
types with the largest sample sizes. Because the g score is
standardized, it provides another way to consider the effect
sizes of these associations by comparing the z-score dif-
ferences between the homozygote genotypes. For example,
the average z-score difference between the homozygotes for
the six SNPs is 0.12 (range: 0.07–0.17), indicating that the
homozygotes differ by about 0.12 of a standard deviation in
their g scores (approximately 2 IQ points on a scale with a
mean of 100 and a standard deviation of 15). This finding
indicates that even with very modest correlations such as
these, homozygotes that differ at a single locus could provide
biological clues into understanding the etiology of g. This
point takes on greater significance when the SNPs are
combined in an SNP set.
SNP set
The additive genotypic values for the six SNPs are uncorre-
lated because the SNPs are not in linkage disequilibrium with
each other. This permits the creation of a composite SNP set
that aggregates the small effects of each SNP and can be
useful for certain purposes such as selecting individuals at
genotypic risk in studies that are not sufficiently large to
Figure 2: A scatter plot showing the 47 top-ranked SNPs
(crosses) against the background of unselected SNPs com-
paring allele frequencies for the low g group (x-axis) and the
high g group (y-axis). The figure also displays the density of
SNPs as a function of low g vs. high g allele frequency differ-
ences; density of SNP clusters increases as the heat map
changes from light (sparse clusters) through to dark (dense
clusters). Allele frequency differences are small, with the majority
of small differences occurring for SNPs with minor allele frequen-
cies of 0.10–0.25, which reflects the overrepresentation of SNPs
with these allele frequencies on the Affymetrix microarray. The
correlation between low and high g allele frequencies was 0.993,
indicating high reliability across the two groups.
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Single nucleotide polymorphism genotypic values were
recoded in a reversed direction for SNPs rs2496143 and
rs11761076 so that high genotypic values for all SNPs
indicate higher g.
In theory, summing the SNP genotypes for the six signif-
icant associations can produce SNP-set scores from 0 to 12.
In practice, however, the low combined probability that
individuals will be homozygous for either all low or all high
alleles results in SNP-set scores that ranged from 1 to 11,
with only three individuals with a SNP-set score of 1 and only
nine individuals with a SNP-set score of 11, which is close to
the expectation of 3 and 10, respectively, based on the
observed genotypic frequencies. Complete genotype data
for all six SNPs were available for 2557 individuals. An
additional 119 individuals who had a minimum of four
genotypes of the six SNPs in stage 2 were included in this
analysis (n ¼ 2676) using a missing data option that
substituted the population mean genotypic value for missing
SNPs. SNP-set scores were normally distributed (Fig. 4).
The correlation between SNP-set scores and g scores is
0.105 (P < 0.00000003, n ¼ 2676). Squaring this correlation
indicates an effect size of 1.1% that is comparable to the sum
of the effect sizes of the six SNPs, which, as noted earlier,
was 1.2%. The correlation between SNP-set scores and g
scores was essentially unchanged when the individuals
with missing data were excluded (r ¼ 0.100, P < 0.0000002,
n ¼ 2557). Figure 5 plots the standardized g score against the
SNP-set scores for the sample of 2676 individuals. It can be
seen that the association is approximately linear, which
indicates additivity of the genotypic values in the SNP set.
The standardized g score difference between SNP-set scores
below 3 and above 8 is 0.24 SD, comparable to a difference of
about 4 IQ points. This difference suggests that selecting on
the basis of extreme SNP-set scores could be effective for
selecting groups with a genetic liability for low or high g,
although the associations of the individual SNPs yield small
effect sizes.
Discussion
In this first genome-wide association scan employing approx-
imately 500 000 SNPs for general cognitive ability (g), six
SNPs survived our two-stage screen for QTLs that are
associated with g across the normal distribution. In stage 1,
which compared allele frequencies derived from pooled DNA
for low and high g groups, a composite of five criteria was
used to nominate SNPs for individual genotyping in stage 2. In
stage 2, for financial reasons, a single SNPlex multiplex of 47
SNPs was used to individually genotype an independent and
representative sample of 3195 individuals. Using an alpha of
0.05 to provide a reasonable balance between false positives
and false negatives in the search for QTLs of very small effect
size, six SNPs yielded significant associations, whereas only
two significant associations would be expected on the basis
of chance.
Table 1: Mean quantitative trait scores and correlations between additive genotypic values and quantitative trait scores
SNP ID Chromosome
Genomic
location Genotype n
Mean g
score (SD) r
Estimated effect
size (%)
rs11691504 2q31.3 Intergenic AA* 601  0.07 (1.03) 0.042 (P ¼ 0.015) 0.2
AC 1368 0.03 (0.98)
CC 711 0.05 (0.98)
rs1378810 3q22.1 Intron 55
(DNAJC13)
AA* 515  0.06 (0.98) 0.062 (P ¼ 0.0007) 0.4
AT 1362  0.02 (1.00)
TT 790 0.11 (0.99)
rs2496143 6p24.1 Intron 5
(TBC1D7)
CC 1005 0.06 (1.00)  0.034 (P ¼ 0.037) 0.1
CT 1321  0.01 (1.01)
TT* 378  0.04 (0.92)
rs11761076 7q32.1 Intergenic AA 447 0.10 (0.94)  0.045 (P ¼ 0.010) 0.2
AG 1316 0.03 (1.01)
GG* 881  0.04 (1.00)
rs174455 11q12.3 Intron 1
(FADS3)
AA 1085  0.02 (0.94) 0.043 (P ¼ 0.013) 0.2
AG 1276 0.02 (1.02)
GG* 329 0.12 (1.03)
rs7195954 16p13.3 Intergenic CC 253  0.01 (0.99) 0.033 (P ¼ 0.043) 0.1
CG 1128  0.02 (1.01)
GG 1274 0.06 (0.97)
Because additive genotypic coding was initially alphabetically ordered (0 ¼ AA, 1 ¼ AB and 2 ¼ BB), the resulting codes produce negative
correlations for SNPs rs11761076 and rs2496143, indicating lower g scores for the B alleles of these SNPs. By squaring the Pearson correlation
coefficient (r), an effect size of the SNP on g can be estimated. The ancestral allele of SNP rs7195954 was not known at the time of writing.
*Individual homozygote for the ancestral alleles of the SNP.
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Butcher et al.Figure 3: Genotype-by-phenotype plots illustrating the effect of genotype (x-axis) on standardized g scores (y-axis). The six
significantly associated SNPs using individuals genotyping are labeled a–e.
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Genome-wide association study for gSmall effect sizes and the use of SNP sets
Genome-wide association is a powerful and systematic tool
for identifying QTL associations; however, a finding of general
significance is that no associations greater than 0.5% were
detected although the effective sample of >2500 provided
95% power to detect them. Given the increased SNP density
of the Affymetrix 500K microarray, it is surprising that this
result does not substantially improve upon our previous work
in cognitive and learning abilities and disabilities using un-
multiplexed assays as well as 10K and 100K microarrays
(Butcher et al. 2005a,b; Meaburn et al. 2007). One explana-
tion is that the sheer number of SNPs exacerbates the
problem of detecting weaker – but true – signals from the
noise caused by 500 000 SNPs. For example, although
the expected proportion of true-positive associations should
be larger in apanel of 500 000 SNPs than,say, 100 000 SNPs,
the number of false positives should be proportionately even
greater. This problem may have contributed to the fact that
our previous study of g using 10K SNP microarrays identified
four SNPs (Butcher et al. 2005b), whereas the present study
with 50 times more SNPs identified only six SNPs. Moreover,
although we had expected that the 500K SNP microarrays
would identify a few SNPs with larger effect sizes, the
average effect sizes of associations in the two studies were
the same. Because none of the four SNPs from our previous
study is on the Affymetrix 500K microarray set, we cannot
directly compare SNP-MaP results for the two studies. From
an indirect perspective, there was only one perfect proxy on
the Affymetrix 500K microarray for any of the SNPs from our
previous study (Butcher et al. 2005b). According to HapMap
(The International HapMap Consortium 2005) data for the
CEPH population, only one SNP (rs11385352, from the 500K
microarray) perfectly tags (r
2 ¼ 1) a SNP (rs991684, from the
10K microarray) reported in our previous study; yet, it showed
no association in the current study. Association may, how-
ever, have been masked by the between-group variance for
rs11385352.
One possible reason for not observing larger, common,
single-locus SNP effects for g is that they do not exist.
Genome-wide association scans based on large samples
can identify SNPs with large effect sizes, as shown in
research on macular degeneration (Klein et al. 2005) and
inflammatory bowel disease (Duerr et al. 2006). By itself, this
possibility warrants the use of genome-wide association
scans. However, it may be that for common disorders and
quantitative traits such as the present genome-wide scan for
g, the main finding is the exclusion ofSNPs oflarge effect size
to the extent that coverage for common variants is virtually
complete. If the largest SNP effects are as small as 0.4% of
the variance, winnowing the wheat from the chaff will be
difficult, requiring extremely large samples, multiple-stage
designs and replication in independent samples. Alternatively,
it may be that there are few common SNPs of large effect and
that there are many more rare variants of larger effect size.
Our data cannot address this issue because, for reasons of
power, we selectively chose SNPs whose minor allele was
common. However, several recent genome-wide association
studies of common disorders including obesity, heart dis-
ease, type 2 diabetes and bipolar disorder also only found
associations of very small effect size (Diabetes Genetics
Figure 4: Ahistogramillustrating thedistribution ofSNP-set
scores. The x-axis scale runs from 0 to 12 because each of the
genotypes for the six SNPs is coded using an additive model with
0, 1 or 2 ‘increaser’ alleles. For each SNP, scores of 2 indicate that
the individual is homozygous for the allele conferring higher g
scores. These scores are summed at each locus for each
individual to create an SNP-set score. The y-axis indicates the
number of individuals with a particular SNP-set score. The
majority of individuals score between 5 and 8 because the SNPs
were chosen on the basis of high minor allele frequency and thus
high heterozygosity.
Figure 5: Agenotype-by-phenotypeplotillustrating therela-
tionship between SNP-set scores and standardized g. The
correlation between the SNP-set scores and the g scores is 0.105
(P < 0.00000003, n ¼ 2676). The association is approximately
linear, which indicates additivity of the genotypic values in the
SNP set.
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2007; Wellcome Trust Case Control Consortium 2007).
Moreover, the authors of these studies acknowledge the
‘winner’s curse’ – the phenomenon whereby an initial study
overestimates the genetic effect size. This suggests that
initial discoveries of associations are liberal estimates of
effect size in that they capitalize on chance, and that the
key to replicable SNP associations is even larger samples.
Nonetheless, the substantial heritability of most common
disorders and quantitative traits such as g means that DNA
polymorphisms are associated with the disorders and traits,
and we must do what it takes to find the genes responsible
for this genetic influence.
Until the six SNPs reported in this study are replicated in
other samples, caution is in order because their average
effect size is only 0.2% of the variance of g in the represen-
tative unselected sample used in stage 2. The small effect
sizes will make replication difficult because a sample of about
4000 individuals is needed to reach 80% power (P < 0.05,
one tailed) to detect an effect size of 0.2%. However, the
composite SNP set could be tested for replication in much
smaller samples. The SNP set of five SNPs has an effect size
of about 1% of the total variance of g. An effect size of 1%
would require a sample of about 780 to reach 80% power to
detect an association between SNP set and g.
SNP locations
Although none of the six SNPs are functionally related to g,
the genomic features surrounding the locations of the six
SNPs are interesting. Three of the SNPs (rs1378810,
rs2496143 and rs174455) are in known genes [DnaJ
(Hsp40) homologue, subfamily C, member 13 (DNAJC13),
TBC1 domain family, member 7 (TBC1D7) and fatty acid
desaturase 3 (FADS3), respectively], but none are in coding
regions; given that only 1.7% of the SNPs on the Affymetrix
500K microarray are in coding regions [Affymetrix annotation
data (July 2007)], this is hardly surprising. One SNP
(rs7195954) lies in a region of known copy number variation
(CNV) and may warrant more detailed CNV analysis. One SNP
(rs11761076) is in close proximity (27 kb) with a gene but
shows no evidence of being in linkage disequilibrium (LD)
with it. One SNP (rs11691504) lies in large gene desert with
no currently documented functional elements nearby. Finally,
and potentially most interesting, is the high LD between
rs1378810 and the 30 untranslated region (UTR) of DNAJC13,
which contains nine predicted conserved mammalian micro
RNA (miRNA) regulatory target sites. None of the SNPs show
a high degree of sequence conservation with other species,
which may indicate human-specific effects.
Limitations
One important limitation is that only 47 of the SNPs nomi-
nated by SNP-MaP in stage 1 were individually genotyped and
tested for replication in the independent stage 2.In the future,
we plan to mine these SNP-MaP data further. However,
rather than enduring the expense of individually genotyping
large numbers of SNPs, our ongoing research has converted
stage 2 to a second independent SNP-MaP screen compara-
ble to the stage 1 SNP-MaP design with 10 independent DNA
pools created from a low g group and 10 pools from a high g
group. By allelotyping these 20 DNA pools on 500K SNP
microarrays, we can conduct much more thorough stage 2
screening. A representative sample will be individually geno-
typed in stage 3 to test for SNPs that pass the hurdles of
stages 1 and 2.
Another limitation is that more sophisticated ways of
analyzing pooled DNA are now available, for example ‘Gene-
Pool’ (Pearson et al. 2007), as well as increased literature
dedicated to design considerations, for example Macgregor’s
frameworks for minimizing measurement variance (Macgre-
gor 2007). However, these methods were not available
when we completed our SNP-MaP screen and selected SNPs
for individual genotyping. Nonetheless, our multiple-criteria
composite for selection that incorporates variance across
independent DNA pools is central to these newer analytic
strategies.
Our study may potentially be limited in six other ways:
1 The SNP-MaP screen did not use k-corrected allele fre-
quency estimates. k-correction improves the accuracy of
absolute estimates of allele frequency forp o o l e dD N A
(Simpson et al. 2005). However, k-correction does not have
much effect on relative estimates of allele frequency differ-
ences, which is the relevant issue when comparing pooled
DNA for groups (Meaburn et al. 2006). Because k-correction
is SNP specific, it is difficult to speculate on which SNPs
would have been chosen had k-correction data been available.
2 SNPs with minor allele frequencies less than 5% were
excluded in the SNP-MaP screen for reasons explained
earlier. Moreover, our multiple-criteria composite preferen-
tially selected SNPs with high minor allele frequencies
(Fig. 2). It seems reasonable to begin by testing the common
variant/common disease QTL hypothesis (Cargill & Daley
2000); in the future, we could investigate less common alleles
(in which case, k-correction becomes more appropriate).
3 We did not observe SNP effects accounting for greater
than 0.4% of the variance; however, this does not necessarily
mean that single-SNP effects accounting for more of the
variance on g do not exist. The power to detect effects is also
contingent on the sensitivity of the SNP-MaP approach as
well as the coverage of the 500K microarray (66% of common
variants captured at r
2 > 0.80 using a single-marker
approach; Pe’er et al. 2006), which are two areas likely to
improve in time.
4 The SNP-MaP screening did not discriminate SNPs in
known regions of copy number variants (Redon et al. 2006;
Wong et al. 2007). The Affymetrix 500K microarray that we
used is not ideally suited to detect copy number variants;
however, the Affymetrix 5.0 (including 420K nonpolymorphic
probes) and Affymetrix 6.0 (including 946K nonpolymorphic
probes) microarrays are much better positioned to detect and
identify copy number variants. However, if copy number
variants were important, we suggest that they would add
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Genome-wide association study for gnoise to our current SNP-MaP screening, thus increasing
false negatives rather than false positives.
5 Our sample was 7 years old and results might differ at
other ages. Although quantitative genetic research indicates
that genetics largely accounts for stability of g from age to
age, some change is genetically driven. For example, from 7
to 10 years, age-to-age genetic correlations are 0.70–0.80
(Davis et al. 2007). Because some of the TEDS sample used
in the present study have been tested at 9 and 10 years and
is now being tested at 12 years, it will be possible to address
the issue of developmental change and continuity of g.
However, given the increased role of heritability (and
decrease of shared environment) in g with age, caution
should be exercised when interpreting the replication of
these SNP associations at other (particularly much older)
ages.
6 Finally, our SNP-MaP screening was confined to the auto-
somes. An analysis of Online Mendelian Inheritance in Man
(OMIM, http://www.ncbi.nlm.nih.gov/omim) shows that over
10% ofsearches for ‘mental retardation’ involved X-linked loci
(Inlow & Restifo 2004), suggesting that a stratified pooled
DNA approach may show novel loci on the X chromosome
that contributes to g.
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